Semaglutide may stimulate the growth of neuroendocrine cancers that express GLP-1 receptors, they found, shedding light on an unanticipated risk for some patients
As GSH cannot readily cross the cellular membrane due to its biochemical properties 35 , we assume that GSH excretion is negligible and do not account for it in the equation
They are indicated for type 2 diabetes management, weight reduction in obesity, and cardiovascular risk reduction, with ongoing investigation into metabolic dysfunction-associated steatohepatitis, chronic kidney disease, and heart failure with preserved ejection fraction
Physician 58 (7), 16271634 (1998)
Non si tratta di incompatibilit assoluta, ma di possibile interferenza funzionale